• Skip to navigation (Press Enter).
  • Skip to main content (Press Enter).
Suche
  • Universitätsklinikum
  • Home
  • Ophthalmology
    • Staff
    • Angiogenesis lab
    • Section Visual Function
    • Glaucoma
    • Histology lab
    • Corneal diseases
    • Hornhautbank
    • Cornea research
    • Cataract surgery
    • LASIK
    • Retinal dystrophies
    • Plastic surgery
    • Retinology
      • ·Protocol for isovolaemic hemodilution
    • Neuro- and pediatric ophthalmology, strabism
    • Neuroprotection lab
    • Low vision aids
    • Uveitis
    • Cellular biology lab
    • Hospital history
  • for Patients
  • for Ophthalmologists
  • for Students
  • Applications
  • Research, clinical studies
  • Events
  • Intranet (local only)
  • “our” man in Tansania
  • Friends of this department
  • Augennetz Südbaden
  • emergency clinic
Grafik unten
Logo
  • Contact
  • How to Find Us
  • Organisations
  • Media
Namensbildlinkesbildmittebildrechtesbild
Printer  Pdf
» Ophthalmology » Retinology » ·Protocol for isovolaemic hemodilution
Google-Suchmaschine
Gesamte Uniklinikseite
Interne Suchmaschine
Aktuelle Uniklinikseite (augenklinik)
Suche nach Stichworten
Begriffe, Krankheiten, Einrichtungen u.v.m., verknüpft mit dem zuständigen Bereich.
Personensuche
Nachname:
Vorname:
Akad. Titel:
Org.-Einheit:
phonetische Suche
Suche nach Einrichtungen:
Such-Bereich:
Bezeichnung:
phonetische Suche
Suche über die Einrichtungen
Im Menüpunkt "Übersicht" sind Einrichtungen unter verschiedenen Gesichtspunkten gruppiert: Kliniken, Abteilungen, Institute, Zentrale Einrichtungen und ähnliches.
Smart-Link
Seitenaufruf mit Smartlink--> Info hier!
smartlink-symbol

Sektion für Retinologie

Protocol for isovolaemic hemodilution
(Freiburg scheme)

1. Inclusion criteria

  • central and branch vein occlusion of less than 8 weeks duration (symptoms noticed by patient)
  • patient between 20 and 80 years of age

2. Exclusion criteria

  • significant ischaemic heart disease (myocardial infarction less than 6 months ago, unstable angina, ischaemic ECG)
  • cerebrovascular event less than 6 months ago
  • grossly abnormal urea and electrolytes
  • significant pulmonary disease
  • haematocrit (PCV) below 38%

3. A full medical examination has to be done with special emphasis on the cardio-vascular system. The following investigations have to be carried out:
medical: blood-pressure, ECG, X-ray, blood-tests (Hb, Plat, WBC, ESR, PCV, Na+, K+, Urea, Crea, B-Glucose, Hb A1C, TG, Chol, Protein), Urinanalysis
ophthalmological: visual acuity, full eye-examination  including direct and indirect ophthalmoscopy and slit-lamp biomicroscopy.

4. Patients will have venesections of 500 ml blood and replacement (at the same time of the bloodletting procedure) with 500 ml 10% Hydroxyethylstarch in the first 1 - 2 weeks to lower the PCV under 35% (about 2-6 haemodilutions). Patients may be admitted for some days, but this is not mandatory. Patients should drink enough (≥ 2l/d) during the time of treatment. After that, weekly repeated haemodilutions whenever PCV exceeds 37%. The total venesection period is about 6 weeks. Before every venesection  the patient's PCV will be measured to assess whether haemodilution is necessary. If significant problems arise (eg. chest pain, shortness of breath) venesection will be discontinued .

5. Follow up
After 6 weeks baseline ophthalmic examinations, coloured photographs, fluorescein-angiogram will be repeated. Patients with an ischemic type of CRVO or neovascularisation will have panretinal photocoagulation recommended (Argon laser).
After 3 and 6 months the mentioned investigations are repeated. Additionally, macular oedema is to be treated if there has not been an increase in visual acuity.
Adjunctive medical (eg. hypertension, diabetes) and ophthalmic (eg. glaucoma) treatment as indicated clinically.

unterer Abschluss
Imprint